557 related articles for article (PubMed ID: 26011580)
1. Overactivation of Complement Alternative Pathway in Postpartum Atypical Hemolytic Uremic Syndrome Patients with Renal Involvement.
Song D; Yu XJ; Wang FM; Xu BN; He YD; Chen Q; Wang SX; Yu F; Song WC; Zhao MH
Am J Reprod Immunol; 2015 Oct; 74(4):345-56. PubMed ID: 26011580
[TBL] [Abstract][Full Text] [Related]
2. Distal Angiopathy and Atypical Hemolytic Uremic Syndrome: Clinical and Functional Properties of an Anti-Factor H IgAλ Antibody.
Rigothier C; Delmas Y; Roumenina LT; Contin-Bordes C; Lepreux S; Bridoux F; Goujon JM; Bachelet T; Touchard G; Frémeaux-Bacchi V; Combe C
Am J Kidney Dis; 2015 Aug; 66(2):331-6. PubMed ID: 26015278
[TBL] [Abstract][Full Text] [Related]
3. Complement activation in diseases presenting with thrombotic microangiopathy.
Meri S
Eur J Intern Med; 2013 Sep; 24(6):496-502. PubMed ID: 23743117
[TBL] [Abstract][Full Text] [Related]
4. Complement factor H, FHR-3 and FHR-1 variants associate in an extended haplotype conferring increased risk of atypical hemolytic uremic syndrome.
Bernabéu-Herrero ME; Jiménez-Alcázar M; Anter J; Pinto S; Sánchez Chinchilla D; Garrido S; López-Trascasa M; Rodríguez de Córdoba S; Sánchez-Corral P
Mol Immunol; 2015 Oct; 67(2 Pt B):276-86. PubMed ID: 26163426
[TBL] [Abstract][Full Text] [Related]
5. [Atypical hemolytic-uremic syndrome related to abnormalities within the complement system].
Frémeaux-Bacchi V; Fakhouri F; Roumenina L; Dragon-Durey MA; Loirat C
Rev Med Interne; 2011 Apr; 32(4):232-40. PubMed ID: 21376430
[TBL] [Abstract][Full Text] [Related]
6. A retrospective study of pregnancy-associated atypical hemolytic uremic syndrome.
Huerta A; Arjona E; Portoles J; Lopez-Sanchez P; Rabasco C; Espinosa M; Cavero T; Blasco M; Cao M; Manrique J; Cabello-Chavez V; Suñer M; Heras M; Fulladosa X; Belmar L; Sempere A; Peralta C; Castillo L; Arnau A; Praga M; Rodriguez de Cordoba S
Kidney Int; 2018 Feb; 93(2):450-459. PubMed ID: 28911789
[TBL] [Abstract][Full Text] [Related]
7. An unusual case of adult-onset still's disease complicated with anti-complement factor H antibodies associated atypical haemolytic uraemic syndrome.
Fung WW; Chao AC; Pang WF; Wong RS; Chow KM; Szeto CC
BMC Nephrol; 2024 May; 25(1):164. PubMed ID: 38745129
[TBL] [Abstract][Full Text] [Related]
8. Immunological features and functional analysis of anti-CFH autoantibodies in patients with atypical hemolytic uremic syndrome.
Guo WY; Song D; Liu XR; Chen Z; Xiao HJ; Ding J; Sun SZ; Liu HY; Wang SX; Yu F; Zhao MH;
Pediatr Nephrol; 2019 Feb; 34(2):269-281. PubMed ID: 30315407
[TBL] [Abstract][Full Text] [Related]
9. Anti-factor H autoantibodies in C3 glomerulopathies and in atypical hemolytic uremic syndrome: one target, two diseases.
Blanc C; Togarsimalemath SK; Chauvet S; Le Quintrec M; Moulin B; Buchler M; Jokiranta TS; Roumenina LT; Fremeaux-Bacchi V; Dragon-Durey MA
J Immunol; 2015 Jun; 194(11):5129-38. PubMed ID: 25917093
[TBL] [Abstract][Full Text] [Related]
10. The role of anti-complement factor H antibodies in the development of atypical haemolytic uremic syndrome: a possible contribution to abnormality of platelet function.
Fujisawa M; Yasumoto A; Kato H; Sugawara Y; Yoshida Y; Yatomi Y; Nangaku M
Br J Haematol; 2020 Apr; 189(1):182-186. PubMed ID: 31879952
[TBL] [Abstract][Full Text] [Related]
11. Atypical hemolytic uremic syndrome: Laboratory characteristics, complement-amplifying conditions, renal biopsy, and genetic mutations.
Hossain MA; Cheema A; Kalathil S; Bajwa R; Costanzo EJ; Cosentino J; Cheng J; Vachharajani T; Asif A
Saudi J Kidney Dis Transpl; 2018; 29(2):276-283. PubMed ID: 29657193
[TBL] [Abstract][Full Text] [Related]
12. [Atypical hemolytic uremic syndrome caused by primary complement defects].
Reusz G
Orv Hetil; 2018 Jun; 159(23):929-936. PubMed ID: 29860884
[TBL] [Abstract][Full Text] [Related]
13. Serological and genetic complement alterations in infection-induced and complement-mediated hemolytic uremic syndrome.
Westra D; Volokhina EB; van der Molen RG; van der Velden TJ; Jeronimus-Klaasen A; Goertz J; Gracchi V; Dorresteijn EM; Bouts AH; Keijzer-Veen MG; van Wijk JA; Bakker JA; Roos A; van den Heuvel LP; van de Kar NC
Pediatr Nephrol; 2017 Feb; 32(2):297-309. PubMed ID: 27718086
[TBL] [Abstract][Full Text] [Related]
14. Rare Functional Variants in Complement Genes and Anti-FH Autoantibodies-Associated aHUS.
Valoti E; Alberti M; Iatropoulos P; Piras R; Mele C; Breno M; Cremaschi A; Bresin E; Donadelli R; Alizzi S; Amoroso A; Benigni A; Remuzzi G; Noris M
Front Immunol; 2019; 10():853. PubMed ID: 31118930
[TBL] [Abstract][Full Text] [Related]
15. Atypical hemolytic uremic syndrome: Korean pediatric series.
Lee JM; Park YS; Lee JH; Park SJ; Shin JI; Park YH; Yoo KH; Cho MH; Kim SY; Kim SH; Namgoong MK; Lee SJ; Lee JH; Cho HY; Han KH; Kang HG; Ha IS; Bae JS; Kim NK; Park WY; Cheong HI
Pediatr Int; 2015 Jun; 57(3):431-8. PubMed ID: 25443527
[TBL] [Abstract][Full Text] [Related]
16. Eculizumab in anti-factor h antibodies associated with atypical hemolytic uremic syndrome.
Diamante Chiodini B; Davin JC; Corazza F; Khaldi K; Dahan K; Ismaili K; Adams B
Pediatrics; 2014 Jun; 133(6):e1764-8. PubMed ID: 24843055
[TBL] [Abstract][Full Text] [Related]
17. Atypical hemolytic uremic syndrome associated with complement factor H autoantibodies and CFHR1/CFHR3 deficiency.
Lee BH; Kwak SH; Shin JI; Lee SH; Choi HJ; Kang HG; Ha IS; Lee JS; Dragon-Durey MA; Choi Y; Cheong HI
Pediatr Res; 2009 Sep; 66(3):336-40. PubMed ID: 19531976
[TBL] [Abstract][Full Text] [Related]
18. Hemolytic Uremic Syndrome in Pregnancy and Postpartum.
Bruel A; Kavanagh D; Noris M; Delmas Y; Wong EKS; Bresin E; Provôt F; Brocklebank V; Mele C; Remuzzi G; Loirat C; Frémeaux-Bacchi V; Fakhouri F
Clin J Am Soc Nephrol; 2017 Aug; 12(8):1237-1247. PubMed ID: 28596415
[TBL] [Abstract][Full Text] [Related]
19. Complement factor H-antibody-associated hemolytic uremic syndrome: pathogenesis, clinical presentation, and treatment.
Hofer J; Giner T; Józsi M
Semin Thromb Hemost; 2014 Jun; 40(4):431-43. PubMed ID: 24799303
[TBL] [Abstract][Full Text] [Related]
20. Favorable four-yr outcome after renal transplantation in a patient with complement factor H antibody and CFHR1/CFHR3 gene mutation-associated HUS.
Grenda R; Jarmużek W; Rubik J; Prokurat S; Miklaszewska M; Drozdz D; Zachwieja K; Ardissino G; Hofer J
Pediatr Transplant; 2015 Sep; 19(6):E130-4. PubMed ID: 26087050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
